EGFR and non-small cell lung carcinoma: On the other hand, different truncated EGFR variants have been identified in glioblastoma50,51 but not NSCLC and have been reported to be associated with increased receptor activation because of the loss of an autoinhibitory region of the C-terminal tail52,53.